Share page with AddThis


Hanetf launches Switzerland’s first medical cannabis ETF

Cannabis_plantLondon-based investment platform Hanetf has launched Switzerland’s first medical cannabis ETF  as one of five new products on the Swiss Stock Exchange.

According to Swiss stock exchange operator SIX, the ETFs enable investors to diversify their portfolios by incorporating “promising” megatrends.

The investment focus of the ETFs range from e-commerce, cloud technologies, medical cannabis and wellness. The underlying indices reflect stocks which target long-term, social and technological megatrends. 

Hanetf co-founder and chief executive Hector McNeill said: “We see megatrend ETFs as being particularly well suited to the Swiss wealth management market as they are typically highly differentiated and target long-term social or technological trends that have seen high growth in recent years.”

Data from SIX shows that its ETF segment registered a trading turnover of more than 50 billion Swiss francs (€46.8 billion) during the first four months this year – a year-on-year growth of 46%.

© 2020 funds europe